Greenwood Capital Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.4M | Buy |
58,299
+2,300
| +4% | +$60.2K | 0.14% | 132 |
|
|
2026
Q1 | $1.57M | Buy |
55,999
+869
| +2% | +$23.1K | 0.17% | 117 |
|
|
2025
Q4 | $1.37M | Buy |
55,130
+2,249
| +4% | +$56.7K | 0.15% | 127 |
|
|
2025
Q3 | $1.35M | Sell |
52,881
-741
| -1% | -$18.3K | 0.16% | 127 |
|
|
2025
Q2 | $1.3M | Sell |
53,622
-4,446
| -8% | -$104K | 0.16% | 119 |
|
|
2025
Q1 | $1.47M | Buy |
58,068
+7,275
| +14% | +$190K | 0.2% | 105 |
|
|
2024
Q4 | $1.35M | Sell |
50,793
-106
| -0.2% | -$2.88K | 0.18% | 110 |
|
|
2024
Q3 | $1.47M | Buy |
+50,899
| New | +$1.48M | 0.19% | 99 |
|
|
2024
Q2 | – | Sell |
-8,821
| Closed | -$245K | – | 251 |
|
|
2024
Q1 | $245K | Sell |
8,821
-176,105
| -95% | -$4.89M | 0.03% | 234 |
|
|
2023
Q4 | $5.32M | Buy |
184,926
+11,853
| +7% | +$358K | 0.69% | 54 |
|
|
2023
Q3 | $5.74M | Sell |
173,073
-28,430
| -14% | -$1.01M | 0.83% | 40 |
|
|
2023
Q2 | $7.39M | Buy |
201,503
+21,148
| +12% | +$823K | 1.04% | 32 |
|
|
2023
Q1 | $7.36M | Sell |
180,355
-5,963
| -3% | -$258K | 1.06% | 33 |
|
|
2022
Q4 | $9.55M | Sell |
186,318
-35,666
| -16% | -$1.71M | 1.57% | 14 |
|
|
2022
Q3 | $9.71M | Sell |
221,984
-24,276
| -10% | -$1.18M | 1.67% | 13 |
|
|
2022
Q2 | $12.9M | Buy |
246,260
+245,708
| +44,512% | +$12.5M | 2.07% | 9 |
|
|
2022
Q1 | $29K | Sell |
552
-226,192
| -100% | -$11.7M | 0.01% | 183 |
|
|
2021
Q4 | $13.4M | Sell |
226,744
-10,413
| -4% | -$516K | 1.9% | 10 |
|
|
2021
Q3 | $10.2M | Buy |
237,157
+76,579
| +48% | +$3.39M | 1.57% | 15 |
|
|
2021
Q2 | $6.29M | Buy |
160,578
+5,382
| +3% | +$209K | 0.95% | 41 |
|
|
2021
Q1 | $5.62M | Sell |
155,196
-61,205
| -28% | -$2.17M | 0.88% | 38 |
|
|
2020
Q4 | $7.96M | Sell |
216,401
-102,462
| -32% | -$3.76M | 1.34% | 25 |
|
|
2020
Q3 | $11.1M | Buy |
318,863
+12,239
| +4% | +$429K | 2.16% | 9 |
|
|
2020
Q2 | $9.51M | Sell |
306,624
-1,814
| -0.6% | -$61.6K | 2.17% | 13 |
|
|
2020
Q1 | $9.55M | Sell |
308,438
-7,647
| -2% | -$261K | 2.8% | 7 |
|
|
2019
Q4 | $11.8M | Buy |
316,085
+6,553
| +2% | +$233K | 2.48% | 7 |
|
|
2019
Q3 | $10.6M | Buy |
309,532
+76,323
| +33% | +$2.78M | 2.57% | 7 |
|
|
2019
Q2 | $9.59M | Buy |
233,209
+9,486
| +4% | +$377K | 2.41% | 7 |
|
|
2019
Q1 | $9.02M | Buy |
223,723
+4,438
| +2% | +$178K | 2.32% | 11 |
|
|
2018
Q4 | $9.08M | Buy |
219,285
+46,631
| +27% | +$1.94M | 2.38% | 8 |
|
|
2018
Q3 | $7.22M | Sell |
172,654
-5,220
| -3% | -$201K | 1.57% | 20 |
|
|
2018
Q2 | $6.12M | Buy |
177,874
+2,816
| +2% | +$96.2K | 1.41% | 27 |
|
|
2018
Q1 | $5.89M | Buy |
175,058
+1,751
| +1% | +$60.2K | 1.44% | 21 |
|
|
2017
Q4 | $5.96M | Sell |
173,307
-2,628
| -1% | -$89.6K | 1.39% | 19 |
|
|
2017
Q3 | $5.96M | Sell |
175,935
-4,391
| -2% | -$141K | 1.48% | 17 |
|
|
2017
Q2 | $5.75M | Buy |
180,326
+7,483
| +4% | +$236K | 1.49% | 17 |
|
|
2017
Q1 | $5.61M | Buy |
172,843
+89
| +0.1% | +$2.81K | 1.47% | 12 |
|
|
2016
Q4 | $5.32M | Buy |
172,754
+23,952
| +16% | +$731K | 1.5% | 15 |
|
|
2016
Q3 | $4.78M | Sell |
148,802
-4,471
| -3% | -$149K | 1.45% | 16 |
|
|
2016
Q2 | $5.12M | Sell |
153,273
-2,737
| -2% | -$87.4K | 1.58% | 13 |
|
|
2016
Q1 | $4.39M | Sell |
156,010
-1,786
| -1% | -$51K | 1.38% | 19 |
|
|
2015
Q4 | $4.83M | Sell |
157,796
-455
| -0.3% | -$14.3K | 1.56% | 15 |
|
|
2015
Q3 | $4.72M | Sell |
158,251
-4,754
| -3% | -$152K | 1.67% | 15 |
|
|
2015
Q2 | $5.18M | Sell |
163,005
-6,105
| -4% | -$199K | 1.57% | 15 |
|
|
2015
Q1 | $5.58M | Sell |
169,110
-2,876
| -2% | -$91.4K | 1.6% | 14 |
|
|
2014
Q4 | $5.08M | Buy |
171,986
+1,711
| +1% | +$49.1K | 1.47% | 20 |
|
|
2014
Q3 | $4.78M | Sell |
170,275
-84,239
| -33% | -$2.36M | 1.47% | 20 |
|
|
2014
Q2 | $7.17M | Buy |
254,514
+106,094
| +71% | +$3.02M | 2.22% | 5 |
|
|
2014
Q1 | $4.52M | Sell |
148,420
-8,614
| -5% | -$257K | 1.45% | 21 |
|
|
2013
Q4 | $4.56M | Buy |
157,034
+913
| +0.6% | +$26.6K | 1.42% | 22 |
|
|
2013
Q3 | $4.25M | Sell |
156,121
-528
| -0.3% | -$14.4K | 1.5% | 20 |
|
|
2013
Q2 | $4.16M | Buy |
+156,649
| New | +$4.33M | 1.81% | 18 |
|
Other funds holding PFE
Greenwood Capital Associates's PFE Position: Q2 2026 in Review
Greenwood Capital Associates increased its Pfizer (PFE) stake by 4.1% in Q2 2026, buying an estimated $60.2K and bringing the position to 58,299 shares worth $1.4M. The position accounts for 0.14% of the portfolio, ranked #132.
Greenwood Capital Associates first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.4M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Greenwood Capital Associates held 58,299 shares of Pfizer worth $1.4M as of Q2 2026.
- Greenwood Capital Associates bought 2,300 Pfizer shares in Q2 2026, an estimated $60.2K.
- Pfizer made up 0.14% of Greenwood Capital Associates's portfolio in Q2 2026, its #132 holding.
- Greenwood Capital Associates first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Greenwood Capital Associates's Pfizer position peaked at $13.4M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.